US Stock MarketDetailed Quotes

RAPT RAPT Therapeutics

Watchlist

1.190
+0.070+6.25%

Trading Nov 27 12:45 ET

41.60MMarket Cap-428P/E (TTM)

RAPT Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

RAPT Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

RAPT Therapeutics Earnings Reports

RAPT Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12 12:04 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Third Quarter 2024 Financial Results

Nov 12 09:36 ET

RAPT Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 08:14 ET

RAPT Therapeutics | 8-K: RAPT Therapeutics Reports Second Quarter 2024 Financial Results

Aug 8 08:09 ET

Analyst Rating

Updated: Nov 13, 2024

Hold

Buy
14.29%
Hold
71.43%
Sell
14.29%

Price Target

No Data

Heat List

Overall